Contrast-enhanced ultrasound (CEUS) has emerged as a pivotal imaging modality in the assessment of liver lesions, offering real-time, non‐invasive visualisation of tissue vascularity and perfusion ...

Hello. I am Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Welcome back to another installment of GI Common Concerns, in ...

A research team from Japan and China examined the potential role of contrast-enhanced three-dimensional ultrasonography (CE 3-D US) in characterizing focal liver lesions. Their results showed that CE ...

WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) ...

The diagnostics advisory committee reviewed the evidence on the clinical and cost effectiveness of contrast-enhanced ultrasound with SonoVue and noted that the technology was assessed in 3 clinical ...

Hepatic adenoma is a benign epithelial neoplasm. The majority of lesions occur in young females, <40 years of age, on oral contraceptives. [6] Lesions will involute to a variable extent if oral ...

An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting ...